COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676

Dr Hariom Kumar Solanki

saurabhsrivas@gmail.com

2020-08-20

Not recruiting

RCT

Randomized

Parallel

Blind label

single-center

Prevention

All the family members of a newly diagnosed Covid-19 patient who are - living with the patient in the last 2 weeks, aged between 18 years and 60 years of age, asymptomatic on the day of diagnosis of the index case.

The following will be excluded from the study: <br/ >1. Pregnant or lactating women <br/ >2. Those with any degree of ARI symptoms or fever. <br/ >3. Person with known history of severe hypersensitivity reaction to previous exposure to Ivermectin. <br/ >4. People with pre-existng severe medical conditions according to the judgement of <br/ >the investigators

3

Department of Community Medicine

18

60

India

Close contacts to covid patients

N/A

180

Symptomatic Covid-19 among the study participantsTimepoint: Between 7 and 10 days of Ivermectin intake

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 3

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]